A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
Clinical trial NCT02714218 · COMPLETED
Trial details
- NCT number
- NCT02714218
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-04
- Primary completion
- 2017-04-20
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.